NIRS for the Diagnosis of Myofascial Pelvic Pain

Part of paid clinical trials in Los Angeles, California.

Sponsor
University of California, Los Angeles
Study ID
NCT07181447
Status
Recruiting

Conditions

  • Myofascial Pelvic Pain

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Pelvic Floor Muscle Assessment by Near-Infrared Spectroscopy — DIAGNOSTIC_TEST
    This study will develop and test an instrument to establish a normal range for near infrared spectroscopy (NIRS) optical changes associate with pelvic floor exercise in adult women based on the test-to test (intra-day) reliability of oxygen kinetics related to contraction of the pelvic floor muscle. We will establish the relationship between the quantitative NIRS data, the condition of Myofascial pelvic musculature and the symptomatology of MPP and related comorbidities. We will also evaluate prospectively the effectiveness of these data in predicting effective treatment modalities. Finally, we will optimize a training regime for non-specialists to allow this technique to be used in a variety of settings. The development of this device and validation of its relevance to diagnosis and treatment of MPP will provide effective care sooner and at a lower cost than current procedures. It will also reduce inequities in the availability of care to underserved populations.

Study Details

Myofascial Pelvic Pain (MPP) is an often-misdiagnosed condition affecting up to 26% of women during their lives and imposing enormous costs on national health care systems. It frequently involves comorbidities such as bladder, bowel, and sexual dysfunction. There are no quantitative measures that adequately guide the physician and accurate diagnosis typically requires an internal examination by a tertiary specialist. This study will develop and test an instrument to establish a normal range for near infrared spectroscopy (NIRS) optical changes associate with pelvic floor exercise in adult women based on the test-to test (intra-day) reliability of oxygen kinetics related to contraction of the pelvic floor muscle. We will establish the relationship between the quantitative NIRS data, the condition of Myofascial pelvic musculature and the symptomatology of MPP and related comorbidities. We will also evaluate prospectively the effectiveness of these data in predicting effective treatment modalities. Finally, we will optimize a training regime for non-specialists to allow this technique to be used in a variety of settings. The development of this device and validation of its relevance to diagnosis and treatment of MPP will provide effective care sooner and at a lower cost than current procedures. It will also reduce inequities in the availability of care to underserved populations by providing an inexpensive, reliable and easily available method for a variety of providers to address MPP.

Key Dates

Start date
Jan 23, 2025
Status verified
Sep 2025
Primary completion
Jul 1, 2026
Completion
Sep 1, 2026

Study Design

Enrollment
110 participants (estimated)

Arms

  • Arm: Control Subjects
    Women age 18 or older without pelvic pain or other genitourinary complaints
  • Arm: Myofascial Pelvic Pain Subjects
    Women age 18 or older with pelvic floor muscle pain or tender points

Primary Outcome Measure

MPP Diagnosis [ Time Frame: 1 day ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UCLA Center for Women's Pelvic HealthLos AngelesCalifornia90095
310-794-5910
Anne L Ackerman, MD PHD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Los Angeles, CA

Related Studies